Brokerages expect Waters Corporation (NYSE:WAT) to announce $670.98 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have issued estimates for Waters’ earnings, with the lowest sales estimate coming in at $663.20 million and the highest estimate coming in at $673.00 million. Waters reported sales of $628.79 million in the same quarter last year, which indicates a positive year over year growth rate of 6.7%. The company is scheduled to announce its next quarterly earnings results on Tuesday, January 23rd.
According to Zacks, analysts expect that Waters will report full-year sales of $670.98 million for the current fiscal year, with estimates ranging from $2.29 billion to $2.30 billion. For the next financial year, analysts anticipate that the company will post sales of $2.42 billion per share, with estimates ranging from $2.40 billion to $2.45 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Waters.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.03. Waters had a net margin of 24.34% and a return on equity of 23.61%. The company had revenue of $565.58 million during the quarter, compared to the consensus estimate of $555.25 million. During the same period in the previous year, the firm posted $1.57 earnings per share. The company’s revenue was up 7.4% on a year-over-year basis.
A number of equities analysts have weighed in on WAT shares. Zacks Investment Research raised shares of Waters from a “hold” rating to a “buy” rating and set a $211.00 target price for the company in a research note on Monday, October 23rd. Barclays PLC boosted their target price on shares of Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 25th. Deutsche Bank AG boosted their target price on shares of Waters from $199.00 to $200.00 and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Cowen Inc reaffirmed a “hold” rating and issued a $190.00 target price on shares of Waters in a research note on Friday, November 3rd. Finally, Goldman Sachs Group Inc started coverage on shares of Waters in a research note on Tuesday, September 26th. They issued a “hold” rating and a $180.00 target price for the company. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $193.62.
Shares of Waters (NYSE:WAT) traded down $0.62 during midday trading on Monday, hitting $195.95. 153,300 shares of the company’s stock were exchanged, compared to its average volume of 516,089. Waters has a one year low of $133.35 and a one year high of $200.71. The company has a market capitalization of $15,584.49, a P/E ratio of 27.22, a PEG ratio of 2.84 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16.
In related news, SVP Rohit Khanna sold 18,400 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $185.78, for a total transaction of $3,418,352.00. Following the completion of the transaction, the senior vice president now owns 22,477 shares in the company, valued at $4,175,777.06. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the transaction, the senior vice president now owns 18,129 shares of the company’s stock, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. In the last quarter, insiders have sold 60,813 shares of company stock valued at $11,820,747. 5.07% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Oppenheimer Asset Management Inc. grew its holdings in Waters by 0.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after purchasing an additional 2 shares during the period. ETF Managers Group LLC acquired a new position in Waters during the second quarter valued at approximately $106,000. Intellectus Partners LLC grew its holdings in Waters by 4.9% during the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after purchasing an additional 31 shares during the period. First Manhattan Co. acquired a new position in Waters during the second quarter valued at approximately $130,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new position in Waters during the second quarter valued at approximately $160,000. Hedge funds and other institutional investors own 92.04% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Expect Waters Corporation (WAT) Will Announce Quarterly Sales of $670.98 Million” was first posted by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://transcriptdaily.com/2017/11/27/zacks-analysts-expect-waters-corporation-wat-will-announce-quarterly-sales-of-670-98-million.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.